Showing results (2171-2180 of 2,402) with videos related to

Sort By:
Pageof 241
Genetic Epidemiology|December 1, 2011
Regression and data mining methods for analyses of multiple rare variants in the Genetic Analysis Workshop 17 mini-exome dataJoan E Bailey-Wilson, Jennifer S Brennan, Shelley B Bull, et al.
Pituitary|November 15, 2011
Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literatureA K Annamalai, A F Dean, N Kandasamy, et al.
Advances in Therapy|April 18, 2026
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension StudyLisa A Beck, Eric L Simpson, Diamant Thaçi, et al.
The British Journal of Dermatology|August 29, 2025
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of 8 clinical trialsKristian Reich, Richard G Langley, Juan Francisco Silvestre Salvador, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunityZheng Yang, Wei Xing Yan, Hong Cai, et al.
JAMA Dermatology|April 19, 2023
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical TrialAmy S Paller, Carsten Flohr, Michael Cork, et al.
Lancet Regional Health. Americas|July 18, 2025
Cannabis legalization and cannabis use disorder in United States Veterans Health Administration patients with and without psychiatric disorders, 2005-2022: a repeated cross-sectional studyDeborah S Hasin, Carol Malte, Melanie M Wall, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2025
Failed Metabolic Adaptation to Stress Underlies Pathogenesis in a Heterozygous Genetic DisorderRobert Harmon, Erin McCarthy, Annette Krol, et al.
Drug and Alcohol Dependence|June 27, 2025
Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021Amar D Mandavia, Jennifer R Fonda, Anne N Banducci, et al.
Pageof 241